Today in Contract Research & Services
Contract Research & Services
ArQule, Daiichi complete patient recruitment in Phase III NSCLC trial
ArQule and Daiichi Sankyo have announced the completion of patient recruitment in Phase III clinical trial of Tivantinib in advanced or metastatic, non-squamous, non-small cell lung cancer (NSCLC) patients.
Contract Research & Services > Clinical Trials > News
Latest Contract Research & Services News by Sector
Select a sector from the list or browse by sector below:
Clinical Trials
Active Biotech, Ipsen reach €10m milestone in Phase III study of tasquinimod
Active Biotech and Ipsen have announced the recruitment of 600 patients in randomized, placebo-controlled Phase III study of tasquinimod in metastatic castrate-resistant prostate cancer (CRPC) patients.
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
Sucampo reports positive data from lubiprostone drug trials
Sucampo Pharmaceuticals' Amitiza (lubiprostone) drug has showed efficacy in treating irritable bowel syndrome associated with constipation (IBS-C) in the two pivotal Phase 3 studies.
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
Contract Research
Scil, Ono partner to develop Affilin therapeutics
Scil Proteins has partnered with Ono Pharmaceutical to discover and develop new Affilin therapeutics to treat various diseases.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
DiaGenic wins NOK7.8m grant to develop blood based diagnostics
DiaGenic has received NOK7.8m from the Norwegian Research Council`s BIA funds for the development of blood based diagnostic tests to detect Alzheimer's disease.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Contract Services
Debiopharm, Vifor sign distribution deal in Switzerland
Debiopharm Group has signed a distribution and commercialization agreement with Vifor Pharma for Pamorelin LA and Salvacyl in Switzerland.
Contract Research & Services > Contract Services > News
Contract Research & Services > Contract Services > News
Furiex, Menarini sign licensing deal to commercialize Priligy
Furiex Pharmaceuticals and Menarini have signed a licensing deal to commercialize Priligy in Europe, Asia, Africa, Latin America and the Middle East.
Contract Research & Services > Contract Services > News
Contract Research & Services > Contract Services > News